Rick Wanstall
VP, Finance and Operations, Rein Therapeutics, Inc.
Companies
- Oncorus, Inc.Chief financial officer May 12, 2022 to May 25, 20221
- Rein Therapeutics, Inc.VP, Finance and Operations Apr 3, 2019 to Mar 30, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Oncorus, Inc.51,000 shares3May 25, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 25, 2022Bought 3,777 shares at $1.20 of Oncorus, Inc.3
- May 20, 2022Bought 1,610 shares at $1.20 of Oncorus, Inc.4
- May 19, 2022Bought 5,000 shares at $1.29 of Oncorus, Inc.5
- May 17, 2022Bought 1 shares at $1.20 of Oncorus, Inc.5
- May 16, 2022Bought 20,620 shares at $1.18 of Oncorus, Inc.6
- May 13, 2022Bought 3,898 shares at $1.15 of Oncorus, Inc.6
- May 12, 2022Bought 14,094 shares at $1.08 of Oncorus, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 24, 2022
- 5SEC EDGARForm 4 filed May 19, 2022
- 6SEC EDGARForm 4 filed May 16, 2022